share_log

Precision Optics Announces Record $9 Million Production Order for High Volume Single-Use Cystoscopy Surgery Program

Precision Optics Announces Record $9 Million Production Order for High Volume Single-Use Cystoscopy Surgery Program

精密光學宣佈了創紀錄的900萬美元大批量一次性膀胱鏡手術項目的生產訂單
GlobeNewswire ·  05/09 21:00

GARDNER, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced a $9 million production order from a leading surgical company to supply single-use endoscope assemblies used in their cystoscopy surgery system. The assembly draws on POC's unique micro-optics and digital imaging technologies. This is the largest order POC has ever received and illustrates the opportunities that single-use applications provide to the Company.

馬薩諸塞州加德納,2024年5月9日(GLOBE NEWSWIRE)——醫療和國防工業先進光學儀器的領先設計師和製造商精密光學公司(納斯達克股票代碼:POCI)今天宣佈了一家領先外科公司的900萬美元生產訂單,供應用於其膀胱鏡手術系統的一次性內窺鏡組件。該組件借鑑了POC獨特的微光學和數字成像技術。這是POC有史以來收到的最大訂單,說明了一次性應用程序爲公司提供的機會。

Production deliveries are scheduled to begin July 2024 and proceed over several quarters. The Company presently estimates approximately $2.2 million in deliveries during its fiscal year ended June 2025, $4.6 million in fiscal 2026, and the remainder in the first half of fiscal 2027. Precision Optics has been performing engineering work for this customer and produced a limited number of units for testing and regulatory purposes. The Company expects a related $0.5 million order for related specialty engineering work over the next six months, bringing the total order value to approximately $9.5 million.

量產交付計劃於2024年7月開始,持續幾個季度。該公司目前估計,截至2025年6月的財年交付量約爲220萬美元,2026財年的交付量爲460萬美元,其餘部分在2027財年上半年。Precision Optics一直在爲該客戶進行工程工作,並生產了有限數量的設備用於測試和監管目的。該公司預計,未來六個月將獲得50萬美元的相關專業工程訂單,使訂單總額達到約950萬美元。

"This landmark purchase order to Precision Optics spotlights how years of engineering and development work is allowing us to meet challenging technical requirements for the physician community at viable price points," commented Dr. Joe Forkey, CEO of Precision Optics. "We expect POC's annual revenue opportunity following delivery of this initial order could grow significantly based on the customer's ongoing success and anticipated growth. Beyond validating POC's capabilities and value to this one customer, this order also demonstrates the single-use market for micro-optics-based endoscopes and confirms that single-use devices are playing a larger and larger role in the overall medical device market."

精密光學首席執行官喬·福基博士評論說:“這份具有里程碑意義的精密光學採購訂單凸顯了多年的工程和開發工作如何使我們能夠以可行的價格滿足醫生界具有挑戰性的技術要求。”“我們預計,根據客戶的持續成功和預期的增長,POC在初始訂單交付後的年收入機會可能會顯著增長。除了驗證POC對該客戶的能力和價值外,該訂單還展示了基於微型光學內窺鏡的一次性市場,並證實了一次性設備在整個醫療器械市場中發揮的作用越來越大。”

Initially, POC will produce all of the ordered units in its own facilities. The customer has the option to transfer production to non-POC manufacturing facilities in exchange for multi-year royalties back to POC.

最初,POC將在自己的設施中生產所有訂購的設備。客戶可以選擇將生產轉移到非POC製造設施,以換取多年特許權使用費返還POC。

The market for medical devices continues to be robust with the single-use endoscope segment growing at a rate two to three times that of the endoscope market in general. POC believes this is due in part to the desire of the medical community to replace reusable products with single-use equivalents to improve patient safety and hospital efficiencies, which is the impetus behind efforts of device companies to introduce new and next generation products as single-use whenever feasible.

醫療器械市場繼續保持強勁,一次性內窺鏡細分市場的增長速度是整個內窺鏡市場的兩到三倍。POC認爲,這在一定程度上是由於醫學界希望將可重複使用的產品替換爲一次性產品,以提高患者安全和醫院效率,這是設備公司努力在可行的情況下以一次性方式推出新一代和下一代產品的動力。

"The combination of POC's unique technical capabilities in the design and manufacture of single-use endoscopes, combined with the successful business model demonstrated by the production and technology licensing strategy, positions us well to capitalize on this rapidly growing market for years to come," Forkey concluded.

Forkey總結道:“POC在設計和製造一次性內窺鏡方面的獨特技術能力,加上生產和技術許可戰略所展示的成功商業模式,使我們能夠在未來幾年充分利用這個快速增長的市場。”

About Precision Optics Corporation
Founded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics and 3D imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture. Utilizing its leading-edge in-house design, prototype, regulatory and fabrication capabilities as well as its Lighthouse Imaging division's electronic imaging expertise and its Ross Optical division's high volume world-wide sourcing, inspecting and production resources, the Company designs and manufactures next-generation product solutions for the most challenging customer requirements. Within healthcare, Precision Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who require more enhanced and smaller imaging systems for minimally invasive surgery, including single-use medical devices, as well as 3D endoscopy systems to support the rapid proliferation of surgical robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical device companies with a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest quality standards and the optimization of size, weight and power. For more information, please visit .

關於精密光學公司
Precision Optics成立於1982年,是一家垂直整合的光學公司,主要致力於通過提供從新產品概念到批量製造的各種服務,將其專有的微光學和三維成像技術應用於醫療保健和國防/航空航天行業。該公司利用其領先的內部設計、原型、監管和製造能力,以及其Lighthouse Imaging部門的電子成像專業知識和羅斯光學部門在全球範圍內的大量採購、檢驗和生產資源,設計和製造下一代產品解決方案,以滿足最具挑戰性的客戶需求。在醫療保健領域,Precision Optics使世界各地的下一代醫療設備公司能夠滿足外科界日益增長的需求,他們需要更強大、更小的微創手術成像系統,包括一次性醫療設備,以及支持手術機器人系統的快速擴散的三維內窺鏡系統。除了這些下一代應用外,Precision Optics幾十年來還爲頂級醫療器械公司提供了各種各樣的光學產品,包括複雜的內窺鏡和專用內窺鏡。該公司還利用其在微光學領域的技術專長來實現前沿的國防/航空航天應用,這些應用需要最高的質量標準以及尺寸、重量和功率的優化。欲了解更多信息,請訪問。

About Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements which express the Company's intentions, beliefs, expectations, strategies, predictions or any other statements related to the Company's future activities or future events or conditions. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by the Company's management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement, except as required by law.

關於前瞻性陳述
本新聞稿包含前瞻性陳述。前瞻性陳述包括但不限於表達公司意圖、信念、預期、戰略、預測的陳述或與公司未來活動或未來事件或狀況相關的任何其他陳述。這些陳述基於當前對公司業務的預期、估計和預測,部分基於公司管理層的假設。這些陳述不能保證未來的表現,涉及難以預測的風險、不確定性和假設。因此,由於多種因素,實際結果和結果可能與前瞻性陳述中表達或預測的結果存在重大差異。任何前瞻性陳述僅代表其發表之日,除非法律要求,否則公司不承擔任何更新任何前瞻性陳述的義務。

Company Contact:
PRECISION OPTICS CORPORATION
22 East Broadway
Gardner, Massachusetts 01440-3338
Telephone: 978-630-1800

公司聯繫人:
精密光學公司
22 東百老匯
馬薩諸塞州加德納 01440-3338
電話:978-630-1800

Investor Contact:
LYTHAM PARTNERS, LLC
Robert Blum
Telephone: 602-889-9700
poci@lythampartners.com

投資者聯繫人:
LTHAM PARTNERS
羅伯特·布魯姆
電話:602-889-9700
poci@lythampartners.com


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論